I guess the frustration is obviously these things are not simple and take time. At the same time it would be nice to clearly understand what the actual status is and what is holding up progress. I assume to a degree many things are not even within the control of Rce, and they probably are as frustrated as the rest of us waiting for feedback maybe?
The Fiona Stanley Burns trial seemed all approved and ready to start a month ago, and the AGM stated "Over 14 days, 10 patients will receive RECCE® 327 daily while a further 20 receive treatment 3 times per week". I wonder are they waiting for Fiona Stanley burns unit to commence when they are ready? From earlier updates it appeared the company was actually being asked to do this trial by a teaching hospital, not sure if that is same hospital trial is now to be held at. So i was assuming those conducting the trial were eager to get started and see how this product performs. I guess we will know when they are good and ready
RCE Price at posting:
$1.11 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)